Thus, activation of the AMPK/mTOR/ULK1 signaling pathway may be beneficial in AD-related pathologies by promoting autophagy, as demonstrated in in vivo and in vitro AD models (Wang and Jia, 2023). Here, ULK1 is linked to Alzheimer disease.